SCHEMBL530054

SCHEMBL530054

NC(=O)c1ccccc1-c1cc[nH]c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCAT2 O15382 1/20 0.61
CSNK1A1 P48729 1/20 0.49
TYRO3 Q06418 1/20 0.49
DYRK1B Q9Y463 1/20 0.49
CHEK1 O14757 1/20 0.46
NUDT1 P36639 1/20 0.43
KDM4E B2RXH2 2/20 0.42
ALDH1A1 P00352 2/20 0.42
MAPT P10636 1/20 0.42
HPGD P15428 1/20 0.42
TSHR P16473 1/20 0.42
HSD17B10 Q99714 1/20 0.42
KEAP1 Q14145 1/20 0.42
NFE2L2 Q16236 1/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
METAP2 P50579 1/20 0.40
ATM Q13315 1/20 0.40
ALOX5AP P20292 1/20 0.39
FEN1 P39748 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1663135 0.84 ALDH1A1 (0.48) BCAT2KDM4EALDH1A1MAPTHPGD
SCHEMBL16322247 0.79 BCAT2 (0.57) BCAT2CSNK1A1TYRO3DYRK1BCHEK1
SCHEMBL5878337 0.78 BCAT2 (0.87) BCAT2CSNK1A1TYRO3DYRK1BCHEK1
SCHEMBL16149659 0.77 BCAT2 (0.91) BCAT2CSNK1A1TYRO3DYRK1BCHEK1
SCHEMBL29427545 0.77 BCAT2 (1.00) BCAT2CSNK1A1TYRO3DYRK1BCHEK1
SCHEMBL27926363 0.77 BCAT2 (0.76) BCAT2CSNK1A1TYRO3DYRK1BCHEK1
SCHEMBL30582476 0.77 BCAT2 (0.83) BCAT2CSNK1A1TYRO3DYRK1BCHEK1
SCHEMBL132986 0.77 BCAT2 (1.00) BCAT2CSNK1A1TYRO3DYRK1BCHEK1
SCHEMBL23102601 0.76 IDO1 (0.44) CHEK1IDO1
SCHEMBL30514077 0.76 BCAT2 (0.74) BCAT2CSNK1A1TYRO3DYRK1BCHEK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016109221-A1 BTK INHIBITORS MERCK SHARP & DOHME CORP. (US) 2016-07-07 WO claimed
CN-101410387-B Pyridyl-and pyrimidinyl-substituted pyrrole-, thiophene-and furan-derivatives as kinase inhibitors NERVIANO MEDICAL SCIENCES SRL 2013-12-18 CN claimed
EP-1689720-A1 PYRAZOLYL DERIVATIVES IN THE FORM OF DRUGS FOR TREATING ACUTE OR CHRONIC NEURONAL REGRESSIONS Aventis Pharma S.A. (FR) 2006-08-16 EP claimed
WO-2005051917-A1 PYRAZOLYL DERIVATIVES IN THE FORM OF DRUGS FOR TREATING ACUTE OR CHRONIC NEURONAL REGRESSIONS AVENTIS PHARMA S.A. (FR) 2005-06-09 WO claimed
CN-112707893-B 1-cyanopyrrolidine compounds as USP30 inhibitors 特殊治疗有限公司 2023-10-31 CN disclosed
WO-2020198053-A1 2-OXO-2,3-DIHYDRO-1H-IMIDAZO[4,5-B]PYRIDIN-6-YL)-4-METHYLBENZAMIDE DERIVATIVES AND SIMILAR COMPOUNDS AS RIPK2 INHIBITORS FOR TREATING E.G. AUTOIMMUNE DISEASES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2020-10-01 WO disclosed
CN-111433202-A 1- (4- (isoxazol-5-yl) -1H-pyrazol-1-yl) -2-methylpropan-2-ol derivatives and related compounds as I L-17 and IFN-gamma inhibitors for the treatment of autoimmune diseases and chronic inflammation 埃慕尼克股份公司 2020-07-17 CN disclosed
CN-110773144-A Catalytic system for preparing amide by hydrolyzing cyano and application thereof 湖南科技学院 2020-02-11 CN disclosed
EP-3286195-A1 INDAZOLONES AS MODULATORS OF TNF SIGNALING AbbVie Inc. (US) 2018-02-28 EP disclosed
WO-2016168638-A1 INDAZOLONES AS MODULATORS OF TNF SIGNALING ABBVIE INC. (US) 2016-10-20 WO disclosed
CN-101410387-B Pyridyl-and pyrimidinyl-substituted pyrrole-, thiophene-and furan-derivatives as kinase inhibitors NERVIANO MEDICAL SCIENCES SRL 2013-12-18 CN disclosed
WO-2012015693-A1 IMIDAZOLE DERIVATIVES MERCK SHARP & DOHME CORP. (US) 2012-02-02 WO disclosed
EP-1891058-A1 HETEROARYL BENZAMIDE DERIVATIVES FOR USE AS GLK ACTIVATORS IN THE TREATMENT OF DIABETES AstraZeneca AB (SE) 2008-02-27 EP disclosed
WO-2006125972-A1 HETEROARYL BENZAMIDE DERIVATIVES FOR USE AS GLK ACTIVATORS IN THE TREATMENT OF DIABETES ASTRAZENECA AB (SE) 2006-11-30 WO disclosed
EP-1689720-A1 PYRAZOLYL DERIVATIVES IN THE FORM OF DRUGS FOR TREATING ACUTE OR CHRONIC NEURONAL REGRESSIONS Aventis Pharma S.A. (FR) 2006-08-16 EP disclosed
WO-2005051917-A1 PYRAZOLYL DERIVATIVES IN THE FORM OF DRUGS FOR TREATING ACUTE OR CHRONIC NEURONAL REGRESSIONS AVENTIS PHARMA S.A. (FR) 2005-06-09 WO disclosed